FDA Inspection 1281106 — CG Bio Co., Ltd.

CG Bio Co., Ltd. — FEI 3017036472

The FDA completed an inspection of CG Bio Co., Ltd. on Sep 11, 2025 in Hwaseong. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 11, 2025
Fiscal Year
2025
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Hwaseong (Korea (the Republic of))

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
310821 CFR 820.70(e)Contamination control, Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.